Can hemolysis of a blood sample cause false elevated results of lactate dehydrogenase (LD) and D-dimer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemolysis Effects on Lactate Dehydrogenase and D-Dimer

Yes, hemolysis causes falsely elevated lactate dehydrogenase (LD) results even at visually undetectable levels, while D-dimer is affected at moderate to high hemolysis levels, making both tests unreliable in hemolyzed samples.

Lactate Dehydrogenase (LD) - Highly Sensitive to Hemolysis

LD is one of the most hemolysis-sensitive analytes and becomes falsely elevated at extremely low levels of hemolysis that cannot be detected by visual inspection alone. 1

Critical Thresholds for LD Interference

  • LD shows clinically meaningful interference at plasma hemoglobin concentrations <0.5 g/L, which corresponds to hemolysis that is essentially invisible to the naked eye 1
  • This occurs because red blood cells contain approximately 150 times more LD than plasma, making even minimal cell lysis catastrophic for accurate measurement 1
  • Samples should be rejected for LD testing when the hemolysis index (H-index) indicates any detectable hemolysis, as the analytically significant bias occurs before clinically significant bias can be assessed 2

Mechanism of LD Elevation

  • Red blood cells are extraordinarily rich in LD (particularly LDH1 and LDH2 isoenzymes), and their rupture releases massive amounts of this enzyme into the surrounding plasma 1
  • The interference is mechanical and unavoidable - there is no correction formula that can reliably adjust for hemolysis effects on LD 2

Practical Management

  • Automatic measurement of H-index is essential rather than relying on visual inspection, as LD interference occurs below the threshold of visual detection 2
  • When H-index values reach ≥10 g/L hemoglobin, all laboratory data become unreliable and should be suppressed entirely 2
  • The only acceptable solution is to reject the sample and request recollection - corrective formulas are discouraged due to inaccuracy and imprecision 2

D-Dimer - Moderately Sensitive to Hemolysis

D-dimer testing is affected by hemolysis, but requires higher levels of hemolysis than LD to produce clinically significant interference.

Critical Thresholds for D-Dimer Interference

  • D-dimer results remain reliable up to hemolysis index +2 (hemoglobin 1.01-2 g/L) for most assays, though this varies by manufacturer 3
  • At hemolysis index +2 and above, D-dimer samples should be rejected as "hemolyzed sample" to ensure accuracy 3
  • Some manufacturer information may underestimate hemolysis interference - one study found the Improgen kit was affected at lower hemolysis levels than stated in the package insert (which claimed tolerance up to hemoglobin >5 g/L) 3

Assay-Specific Variability

  • Different D-dimer assays use different monoclonal antibodies to fibrin fragments, creating substantial variability in hemolysis susceptibility between manufacturers 4
  • The Fibrin Assay Comparison Trial demonstrated considerable variations in specificity for crosslinked fibrin across 12 different D-dimer manufacturers 4
  • Laboratories must validate hemolysis interference under their own conditions rather than relying solely on manufacturer specifications 3

Mechanism of D-Dimer Interference

  • While the exact mechanism is not fully elucidated in the provided evidence, hemolysis likely interferes through release of cellular components that cross-react with the monoclonal antibodies used in D-dimer assays 4
  • Fibrin degradation products (FDPs) and other fragments can cause over- or underestimation of D-dimer depending on the specific assay methodology 4

Practical Management

  • Samples with hemolysis index +2 or higher should be rejected for D-dimer testing and a new sample requested 3
  • When H-index indicates moderate hemolysis (1.01-2.50 g/L hemoglobin), results can potentially be released with a comment describing potential bias and recommending recollection if the variation might exceed the reference change value 2
  • For critical clinical decisions (such as ruling out pulmonary embolism or deep vein thrombosis), never rely on D-dimer results from visibly hemolyzed samples - always request a new specimen 5

Common Pitfalls to Avoid

  • Never use visual inspection alone to assess hemolysis for LD testing - automated H-index measurement is mandatory 2
  • Do not apply correction formulas to adjust for hemolysis interference in either LD or D-dimer - these are unreliable and should be avoided 2
  • Verify manufacturer claims about hemolysis tolerance under your own laboratory conditions, as package insert information may be inaccurate 3
  • For D-dimer specifically, remember that a positive result cannot confirm thrombosis regardless of sample quality - imaging confirmation is always required before anticoagulation 5
  • When hemolysis is severe (H-index ≥10 g/L), suppress all results rather than attempting selective reporting 2

References

Research

Effect of hemolysis on D-dimer testing measured with the Improgen kit: is all manufacturer information correct?

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

D-Dimer Testing in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.